What do we know about Dabigatran in Patients with Cardiovascular Disease?

Based on the patient characteristics of an AF patient with cardiovascular comorbidities Dr. John W. Eikelboom will review existing data from multiple sources including RE-LY subgroup data, GLORIA AF and RE-DUAL PCI to support the dabigatran treatment decision for this patient

LEAVE YOUR COMMENT

Your email address will not be published.